Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report)'s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $54.80 and traded as high as $68.33. Pro-Dex shares last traded at $66.94, with a volume of 41,854 shares changing hands.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on the stock. Wall Street Zen upgraded shares of Pro-Dex from a "hold" rating to a "buy" rating in a research note on Saturday, June 13th. Weiss Ratings upgraded shares of Pro-Dex from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Thursday, August 6th. Ascendiant Capital Markets upped their target price on shares of Pro-Dex from $56.00 to $70.00 and gave the company a "buy" rating in a report on Tuesday, May 12th. Finally, Zacks Research upgraded shares of Pro-Dex to a "hold" rating in a research note on Tuesday, May 19th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $70.00.
View Our Latest Stock Analysis on PDEX
Pro-Dex Trading Up 0.1%
The company has a quick ratio of 2.14, a current ratio of 3.67 and a debt-to-equity ratio of 0.32. The company has a fifty day moving average of $61.67 and a two-hundred day moving average of $54.80. The stock has a market capitalization of $213.74 million, a price-to-earnings ratio of 18.49 and a beta of 0.02.
Insider Activity at Pro-Dex
In other news, CEO Kirk Richard Lee Van, Jr. sold 4,128 shares of the firm's stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $62.36, for a total value of $257,422.08. Following the completion of the sale, the chief executive officer owned 89,707 shares in the company, valued at approximately $5,594,128.52. This trade represents a 4.40% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 45.90% of the company's stock.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in the company. Morgan Dempsey Capital Management LLC lifted its position in Pro-Dex by 6.2% in the first quarter. Morgan Dempsey Capital Management LLC now owns 5,808 shares of the medical instruments supplier's stock valued at $286,000 after purchasing an additional 339 shares during the period. Wells Fargo & Company MN increased its position in Pro-Dex by 65.4% during the 4th quarter. Wells Fargo & Company MN now owns 2,314 shares of the medical instruments supplier's stock worth $89,000 after purchasing an additional 915 shares during the period. Los Angeles Capital Management LLC acquired a new position in Pro-Dex during the 4th quarter worth approximately $37,000. Bank of America Corp DE raised its stake in shares of Pro-Dex by 173.3% during the 2nd quarter. Bank of America Corp DE now owns 1,692 shares of the medical instruments supplier's stock worth $74,000 after buying an additional 1,073 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in shares of Pro-Dex during the 2nd quarter worth approximately $50,000. 15.28% of the stock is owned by hedge funds and other institutional investors.
About Pro-Dex
(
Get Free Report)
Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.
Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Pro-Dex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pro-Dex wasn't on the list.
While Pro-Dex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
